United Capital Financial Advisors LLC Has $41.60 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

United Capital Financial Advisors LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,695 shares of the medical equipment provider’s stock after selling 2,732 shares during the quarter. United Capital Financial Advisors LLC’s holdings in Intuitive Surgical were worth $41,598,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Norges Bank acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $2,401,493,000. Proficio Capital Partners LLC raised its stake in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares during the period. Raymond James Financial Inc. bought a new position in Intuitive Surgical in the fourth quarter worth approximately $313,769,000. Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.7 %

ISRG opened at $490.13 on Tuesday. The firm has a 50-day moving average price of $530.71 and a 200-day moving average price of $532.76. The company has a market capitalization of $174.57 billion, a price-to-earnings ratio of 76.46, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ISRG shares. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Truist Financial reduced their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.